Skip to Content

Cancer Research & Clinical Trials

The cancer team at Adventist HealthCare recognizes the important role that clinical trials play in the study of new, innovative treatments or strategies that may lead to prevention, earlier detection, better treatments or cures for conditions such as cancer. Our expert cancer research team includes physicians and clinical research nurses as well as research associates and assistants who are involved with more than 65 cancer studies each year.

Search or Browse Cancer Clinical Trials

Showing 1-5 of 5

Sorted By:

  • ERA 223

    Study to determine if the addition of radium-223 dichloride to standard treatment is able to prolong life and to delay events specific for prostate cancer.

  • PRIMCAB

    Study to demonstrate the superiority in term of radiographic Progression-Free Survival (rPFS) of cabazitaxel in patients with metastatic Castration-Resistant Prostate Cancer.

  • REASSURE

    Observational study in the routine clinical practice setting to evaluate the short and long term safety profile of Radium-223 in metastatic castration resistant prostate cancer patients.

  • SPARTAN

    The purpose of this study is to evaluate the efficacy and safety of ARN-509 in adult men with high-risk non-metastatic castration-resistant prostate cancer.

  • VIABLE

    Study to determine whether DCVAC/PCa added onto Standard of Care Chemotherapy can improve survival times for patients with Metastatic Castration Resistant Prostate Cancer.

Showing trials 1-5 of 5

Clincal Trials & Research Studies

Patient Stories

We’re writing new chapters in the lives of our patients, their families and our community daily. These are their stories:

Local Health News - In Your Inbox

Join over 40k of your friends & neighbors and get the latest news about community health programs and events when you sign-up for Adventist HealthCare & You Digital.

Subscribe Today!